Atlas Trials

Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma

Clinical trial NCT07367685 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07367685
Sponsor
The Second Affiliated Hospital of Fujian Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent/Refractory B-cell Lymphoma
Start date
2026-05-01
Primary completion
2028-04-30
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.